T3	Effect 0 32	Secondary acute myeloid leukemia
T5	Treatment 39 56	etoposide therapy
T7	Drug 39 48	etoposide
T8	Treat-Disorder 61 96	haemophagocytic lymphohistiocytosis
T4	Adverse_event 33 38	after
E1	Adverse_event:T4